High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus

Human Gene Therapy

Volumn 9, Issue 16, 1998, Pages 2353-2362

  Gao, Guang Ping ^b   Qu, Guang ^b   Faust, Lynn Z ^b   Engdahl, Ryan K ^b   Xiao, Weidong ^b   Hughes, Joseph V ^b   Zoltick, Philip W ^b   Wilson, James M ^a  

^a WISTAR INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

ADENO ASSOCIATED VIRUS; ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; EXPRESSION VECTOR; GENE AMPLIFICATION; HELA CELL; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; PLASMID; POLYCYTHEMIA; PROMOTER REGION; SHUTTLE VECTOR; SKELETAL MUSCLE; VIRUS RECOMBINANT; VIRUS REPLICATION;

EID: 0032212276     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.16-2353     Document Type: Article

References (10)

1. ALLEN, J.M., DEBELAK, D.J., REYNOLDS, T.C., and MILLER, A.D. (1997). Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production. J. Virol. 71, 6816-6822.
2. BENNETT, J., DUAN, D., ENGELHARDT, J., and MAGUIRE, A.M. (1997). Real-time non-invasive in vivo assessment of adeno-associated virus-mediated retinal transduction. Invest. Ophthalmol. Vis. Sci. 38, 2857-2863.
3. CLARK, K.R., VOULGAROPOULOU, F., FRALEY, D.M., and JOHNSON, P.R. (1995). Cell lines for the production of recombinant adeno-associated virus. Hum. Gene Ther. 6, 1329-1341.
4. FAN, P.-D., and DONG, J.-Y. (1997). Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV. Hum. Gene Ther. 8, 87-98.
5. FERRARI, F.K., SAMULSKI, T., SHENK, T., and SAMULSKI, R.J. (1996). Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70, 3227-3234.
6. FERRARI, F.K., XIAO, X., MCCARTY, D., and SAMULSKI, R.J. (1997). New developments in the generation of Ad-free, high-titer rAAV gene therapy vectors. Nature Med. 3, 1295-1297.
7. FISHER, K.J., GAO, G.-P., WEITZMAN, M.D., DEMATTEO, R., BURDA, J.F., and WILSON, J.M. (1996a). Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70, 520-532.
8. FISHER, K.J., KELLEY, W.M., BURDA, J.F., and WILSON, J.M. (1996b). A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome. Hum. Gene Ther. 7, 2079-2087.
9. FISHER, K.J., JOOSS, K., ALSTON, J., YANG, Y., HAECKER, S.E., HIGH, K., PATHAK, R., RAPER, S.E., and WILSON, J.M. (1997). Recombinant adeno-associated virus for muscle-directed gene therapy. Nature Med. 3, 306-312.
10. YANG, Q., CHEN, F., and TREMPE, J.P. (1994). Characterization of cell lines that inducibly express the adeno-associated virus rep proteins. J. Virol. 68, 4847-4856.